Tempus AI Makes Strong Market Debut with $410.7 Million IPO

Explore how Tempus AI Inc. is leveraging artificial intelligence to revolutionize medical diagnostics in oncology, neuropsychiatry, cardiology, and radiology, following its successful $410.7 million IPO.